Technology-Assisted Cholesterol Trial in Consumers (TACTiC)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1196 participants.
Also called NCT04964544
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,196 participants
- Sponsor
- Registry
-
NCT04964544
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04964544. Allocation not applicable; no masking; primary purpose treatment. Start 2021-07-08 (actual); primary completion 2023-03-01 (actual). Results posted on 2024-10-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Technology-Assisted Cholesterol Trial in Consumers (TACTiC)
- Acronym
- TACTiC
- Condition
- High Cholesterol
- Intervention (Combination product)
- 5 mg rosuvastatin calcium with a Web App (combination product)
- Lead sponsor
- AstraZeneca
- Collaborator
- Concentrics Research
- Collaborator
- Idea Evolver
- Collaborator
- The Cleveland Clinic
Record details
- Record id
cardio:ct-nct04964544- Content hash
5d4582421fab075176cc26118d812e283b552ddf5fa27f25e7c01dfd5bb71495